January 7, 2019
The University of Lausanne (UNIL) is offering an International Master in Vaccinology (IMVACC) developed by the Swiss Vaccine Research Institute (SVRI) and the Health Sciences e-Training Foundation (HSeT) in collaboration with the Lausanne University Hospital (CHUV)
The 2016 class. All students have completed their first year and all passed the final exam. Presently one student defended his master project and his is the first to receive the 60 ETCS diploma from the University of Lausanne. The other students will defend their master thesis in the coming years
The 2018 class. All students have completed the first year and will take the final exam on January 16 2019. They will present their master thesis project
The 2019 class. Ten candidates have successfully registered and are starting the program with a kickoff meeting on January 14-16 in Lausanne, Switzerland